Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Amazon | P. Bezos Jeffrey | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 174.33 per share. | 09 Feb 2024 | 2,196,995 | 971,303,711 (9%) | 0% | 174.3 | 383,006,752 | Common Stock, par value $.01 per share |
| National Cinemedia Inc | F. Lesinski Thomas | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 2,066,667 | 2,066,667 | - | - | Restricted Stock Units | |
| Amazon | P. Bezos Jeffrey | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 174.04 per share. | 09 Feb 2024 | 2,033,454 | 964,649,117 (9%) | 0% | 174.0 | 353,897,251 | Common Stock, par value $.01 per share |
| Amazon | Jeffrey P. Bezos | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 172.27 per share. | 09 Feb 2024 | 1,852,953 | 968,402,317 (9%) | 0% | 172.3 | 319,211,919 | Common Stock, par value $.01 per share |
| SES AI Corp (Class A) | Hu Qichao | Director, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,779,661 | 3,130,268 | - | 0 | Class A Common Stock | |
| SES AI Corp (Class A) | Hu Qichao | Director, CEO & CHAIRMAN, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,779,661 | 1,779,661 | - | - | Performance Vesting Restricted Stock Units | |
| Amazon | Jeffrey Bezos P. | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 173.10 per share. | 09 Feb 2024 | 1,719,746 | 966,682,571 (9%) | 0% | 173.1 | 297,693,880 | Common Stock, par value $.01 per share |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 1,566,405 | 1,566,405 (1%) | 1% | 0 | Common Stock | |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 1,566,405 | 89,766 (0%) | 1% | 0 | Common Stock | |
| Amazon | Jeffrey P. Bezos | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.99 per share. | 09 Feb 2024 | 1,408,408 | 974,845,711 (9%) | 0% | 171.0 | 240,830,303 | Common Stock, par value $.01 per share |
| Amazon | Jeffrey Bezos P. | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 173.14 per share. | 09 Feb 2024 | 1,174,766 | 973,500,706 (9%) | 0% | 173.1 | 203,402,157 | Common Stock, par value $.01 per share |
| Amazon | Bezos P. Jeffrey | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 174.79 per share. | 09 Feb 2024 | 1,048,441 | 970,255,270 (9%) | 0% | 174.8 | 183,256,268 | Common Stock, par value $.01 per share |
| National Cinemedia Inc | Y. Ng Ronnie | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 1,033,334 | 1,033,334 | - | - | Restricted Stock Units | |
| Sirius XM Holdings Inc | James E. Meyer | Director | 09 Feb 2024 | 800,000 | 1,091,472 (0%) | 0% | 4.9 | 3,935,920 | Common Stock | |
| Recursion Pharma Inc (Class A) | Christopher Gibson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 666,898 | 666,898 | - | - | Stock Option (Right to Buy) | |
| Semileds Corp | Tri Doan Trung | Director, Chairman and CEO, Ten Percent Owner | 09 Feb 2024 | 629,921 | 1,275,999 (35%) | 17% | 1.3 | 800,000 | Common Stock | |
| SES AI Corp (Class A) | Nealis Jing | CHIEF FINANCIAL OFFICER | 09 Feb 2024 | 610,593 | 2,108,053 | - | 0 | Class A Common Stock | ||
| SES AI Corp (Class A) | Nealis Jing | CHIEF FINANCIAL OFFICER | 09 Feb 2024 | 610,593 | 610,593 | - | - | Performance Vesting Restricted Share Units | ||
| Enphase Energy | Kothandaraman Badri | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.29 per share. | 09 Feb 2024 | 557,660 | 1,947,810 (1%) | 0% | 1.3 | 719,381 | Common Stock |
| Enphase Energy | Kothandaraman Badri | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 557,660 | 0 | - | - | Stock Option (Right to Buy) | |
| National Cinemedia Inc | VG Maria Woods | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 516,668 | 516,668 | - | - | Restricted Stock Units | |
| National Cinemedia Inc | Felenstein Scott D. | President - Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 516,667 | 516,667 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Joseph K. Belanoff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 500,000 | 500,000 | - | - | Stock option (right to buy) | |
| Lyell Immunopharma Inc | Matthew Lang | Chief Business Officer | 09 Feb 2024 | 500,000 | 500,000 | - | - | Option (right to buy) | ||
| Recursion Pharma Inc (Class A) | Tina Marriott Larson | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 447,917 | 447,917 | - | - | Stock Option (Right to Buy) | |
| GSK PLC (ADR) | Emma N. Walmsley | Executive Director,Chief Executive Officer | 09 Feb 2024 | 441,309 | 8,232,494 (0%) | 0% | 0 | Ords 0.31p | ||
| GSK PLC (ADR) | Emma Walmsley N. | Executive Director,Chief Executive Officer | 09 Feb 2024 | 441,309 | 8,673,803 (0%) | 0% | 0 | Ords 0.31p | ||
| SES AI Corp (Class A) | Hong Gan | CHIEF SCIENCE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 423,728 | 875,001 | - | 0 | Class A Common Stock | |
| SES AI Corp (Class A) | Gan Hong | CHIEF SCIENCE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 423,728 | 423,728 | - | - | Performance Vesting Restricted Stock Units | |
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | |
| Lyell Immunopharma Inc | Charles Newton | Chief Financial Officer | 09 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (right to buy) | ||
| Amazon | Jeffrey Bezos P. | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 174.75 per share. | 09 Feb 2024 | 392,696 | 964,256,421 (9%) | 0% | 174.8 | 68,623,783 | Common Stock, par value $.01 per share |
| Roblox Corp (Class A) | P. Anthony Lee | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Feb 2024 | 380,199 | 4,430,878 | - | 0 | Class A Common Stock | |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 348,380 | 348,380 | - | - | Stock Option (Right to Buy) | |
| SES AI Corp (Class A) | Pilkington Kyle | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 338,983 | 564,883 | - | 0 | Class A Common Stock | |
| SES AI Corp (Class A) | Kyle Pilkington | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 338,983 | 338,983 | - | - | Performance Vesting Restricted Stock Units | |
| Recursion Pharma Inc (Class A) | Gibson Christopher | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 333,449 | 1,119,300 | - | 0 | Class A Common Stock | |
| Phibro Animal Health Corp (Class A) | Glenn David C. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 300,000 | 300,000 | - | - | Restricted Stock Units | |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.47 per share. | 09 Feb 2024 | 296,639 | 1,651,171 (1%) | 0% | 122.5 | 36,329,378 | Common Stock |
| Kore Grp Holdings Inc | Bahl Romil | Director, Pres., Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 296,521 | 1,164,134 | - | 0 | Common Stock | |
| Kore Grp Holdings Inc | Bahl Romil | Director, Pres., Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 296,521 | 593,040 | - | - | Restricted Stock Units | |
| Urban Edge Properties | Olson Jeffrey S. | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 286,530 | 286,530 | - | - | 2023 LTIPs | |
| Voyager Therapeutics Inc | W. Sandrock Alfred | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 260,000 | 260,000 | - | - | Stock Option (Right to Buy) | |
| Recursion Pharma Inc (Class A) | Larson Tina Marriott | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 223,958 | 648,161 | - | 0 | Class A Common Stock | |
| American Healthcare REIT Inc | Danny Prosky | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 222,222 | 222,222 | - | 0 | Common Stock | |
| GSK PLC (ADR) | Barron Hal V | Non-Executive Director | 09 Feb 2024 | 214,754 | 1,491,214 (0%) | 0% | 0 | Ords 0.31p | ||
| Snowflake Inc (Class A) | Slootman Frank | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.88 per share. | 09 Feb 2024 | 213,922 | 394,065 | - | 8.9 | 1,899,627 | Class A Common Stock |
| Snowflake Inc (Class A) | Slootman Frank | Director, CEO and Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 213,922 | 10,595,364 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | Guyer William | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Atabak Mokari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Hunt Hazel | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Robb Charles G. | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Maduck Sean | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | - | Stock option (right to buy) | |
| Lyell Immunopharma Inc | Seely Lynn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 200,000 | - | 0 | Common Stock | |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.09 per share. | 09 Feb 2024 | 200,000 | 1 | - | 44.1 | 8,817,240 | Class A Common Stock |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 734,730 | - | - | Stock Option (Right to Buy) | |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.08 per share. | 09 Feb 2024 | 200,000 | 200,001 | - | 0.1 | 15,180 | Class A Common Stock |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.08 per share. | 09 Feb 2024 | 200,000 | 200,001 | - | 0.1 | 15,180 | Class A Common Stock |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 200,000 | 934,730 | - | - | Stock Option (Right to Buy) | |
| Credo Tech Grp Holding Ltd | Lam Yat Tung | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.54 per share. | 09 Feb 2024 | 187,278 | 1,987,709 | - | 22.5 | 4,220,460 | Ordinary Shares |
| nVent Electric PLC | Hogan J. Randall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.52 per share. | 09 Feb 2024 | 184,572 | 192,849 (0%) | 0% | 22.5 | 4,156,561 | Ordinary Shares |
| nVent Electric PLC | J. Hogan Randall | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 184,572 | 0 | - | - | Employee Stock Option (right to buy) | |
| nVent Electric PLC | Randall Hogan J. | Director | Sale of securities on an exchange or to another person at price $ 64.03 per share. | 09 Feb 2024 | 184,572 | 8,277 (0%) | 0% | 64.0 | 11,818,090 | Ordinary Shares |
| Recursion Pharma Inc (Class A) | Michael Secora | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 174,190 | 1,163,863 | - | 0 | Class A Common Stock | |
| Amazon | P. Jeffrey Bezos | Director, Executive Chair, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 172.04 per share. | 09 Feb 2024 | 170,239 | 974,675,472 (9%) | 0% | 172.0 | 29,287,901 | Common Stock, par value $.01 per share |
| Warby Parker Inc (Class A) | Miller Steven | Chief Financial Officer | 09 Feb 2024 | 168,870 | 168,870 | - | - | Restricted Stock Units | ||
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.08 per share. | 09 Feb 2024 | 163,521 | 36,480 | - | 44.1 | 7,208,643 | Class A Common Stock |
| Credo Tech Grp Holding Ltd | Tung Yat Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.55 per share. | 09 Feb 2024 | 156,790 | 1,968,607 | - | 22.5 | 3,535,097 | Ordinary Shares |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 09 Feb 2024 | 156,290 | 7,245,668 (10%) | 0% | 85.2 | 13,311,219 | Common Stock | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 152,990 | 152,990 | - | - | Restricted Stock Units | |
| Corcept Therapeutics Inc | Douglas Joseph Lyon | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| Apollo Global (Class A) (New) | C. Zelter James | Director, Co-President (See Remarks) | Sale of securities on an exchange or to another person at price $ 109.16 per share. | 09 Feb 2024 | 150,000 | 1,454,588 (0%) | 0% | 109.2 | 16,374,570 | Common Stock |
| American Healthcare REIT Inc | Brian S. Peay | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 148,148 | 148,148 | - | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.53 per share. | 09 Feb 2024 | 145,013 | 2,174,987 | - | 22.5 | 3,266,418 | Ordinary Shares |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.52 per share. | 09 Feb 2024 | 144,603 | 2,125,397 | - | 22.5 | 3,257,110 | Ordinary Shares |
| Urban Edge Properties | S. Jeffrey Olson | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 136,586 | 136,586 | - | - | LTIP Units (2024 LTI Time) | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 09 Feb 2024 | 131,790 | 7,513,878 (11%) | 0% | 82.5 | 10,876,629 | Common Stock | |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 130,969 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.44 per share. | 09 Feb 2024 | 130,969 | 439,283 (0%) | 0% | 90.4 | 11,844,836 | Common Stock |
| Urban Edge Properties | Mark J. Langer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 130,919 | 130,919 | - | - | 2023 LTIPs | |
| Voyager Therapeutics Inc | Alfred W. Sandrock | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 130,000 | 347,987 (0%) | 0% | 0 | Common Stock | |
| Urban Edge Properties | Mooallem Jeffrey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 128,817 | 128,817 | - | - | 2023 LTIPs | |
| SES AI Corp (Class A) | Gang Li | CHIEF MANUFACTURING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 127,118 | 252,641 | - | 0 | Class A Common Stock | |
| SES AI Corp (Class A) | Li Gang | CHIEF MANUFACTURING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 127,118 | 127,118 | - | - | Performance Vesting Restricted Stock Units | |
| Genie Energy Ltd (Class B) | Jonas Howard S. | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 126,176 | 0 | - | - | Employee Stock Option (right to buy) | |
| Genie Energy Ltd (Class B) | Howard Jonas S. | Director, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.05 per share. | 09 Feb 2024 | 126,176 | 309,509 (1%) | 0% | 8.1 | 1,015,717 | Class B Common Stock, par value $.01 per share |
| American Healthcare REIT Inc | Gabriel M. Willhite | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 125,926 | 125,926 | - | 0 | Common Stock | |
| Conoco Phillips | Lance Ryan M. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 116,510 | 0 | - | - | Stock Units | |
| Conoco Phillips | Ryan Lance M. | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 116,510 | 134,697 (0%) | 0% | - | Common Stock | |
| GSK PLC (ADR) | Hal V Barron | Non-Executive Director | Sale of securities on an exchange or to another person at price $ 20.92 per share. | 09 Feb 2024 | 115,432 | 1,375,782 (0%) | 0% | 20.9 | 2,414,837 | Ords 0.31p |
| Yum Brands | Gibbs David W. | Director, Chief Executive Officer | 09 Feb 2024 | 105,933 | 105,933 | - | - | Stock Appreciation Right | ||
| EverQuote Inc (Class A) | David B. Blundin | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.43 per share. | 09 Feb 2024 | 100,402 | 903,614 (7%) | 0% | 15.4 | 1,549,203 | Class A Common Stock |
| Flagstar Fin Inc | Schoels Peter | Director | Purchase of securities on an exchange or from another person at price $ 4.15 per share. | 09 Feb 2024 | 100,000 | 147,438 (0%) | 0% | 4.1 | 414,750 | Common Stock |
| Voyager Therapeutics Inc | Robin Swartz | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Sky Quarry Inc | Darryl Andre Delwo | CFO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 100,000 | 125,000 | - | 0 | Common Shares | |
| Coherus Biosciences Inc | Wahlstrom L. Mats | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 99,988 | 0 (0%) | 0% | 0 | Common Stock | |
| Coherus Biosciences Inc | Wahlstrom L. Mats | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 99,988 | 99,988 (0%) | 0% | 0 | Common Stock | |
| Recursion Pharma Inc (Class A) | Mauro J. David | Chief Medical Officer | 09 Feb 2024 | 99,537 | 99,537 | - | - | Stock Option (RIght to Buy) | ||
| Arista Networks | Kenneth Duda | Director, CTO and SVP Software Eng. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 99,080 | 99,080 | - | - | Restricted Stock Unit-14 | |
| Johnson & Johnson | Duato Joaquin | Director, CEO and Chairman of the Board | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.76 per share. | 09 Feb 2024 | 98,662 | 340,621 (0%) | 0% | 156.8 | 15,466,255 | Common Stock |
| Roivant Sciences Ltd | Venker Eric | President & COO | Sale of securities on an exchange or to another person at price $ 10.92 per share. | 09 Feb 2024 | 96,950 | 532,207 | - | 10.9 | 1,058,694 | Common Shares |
| Roivant Sciences Ltd | Eric Venker | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 09 Feb 2024 | 96,950 | 629,157 | - | 3.9 | 373,258 | Common Shares |
| Roivant Sciences Ltd | Venker Eric | President & COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 96,950 | 12,526,234 | - | - | Stock Option (Right to Buy) | |
| Payoneer Global Inc | Ordonez Beatrice | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 09 Feb 2024 | 91,458 | 2,032,028 | - | 5.0 | 457,555 | Common Stock |
| Bancorp Inc | Damian Kozlowski M. | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 91,136 | 652,522 (1%) | 0% | - | Common Stock | |
| SentinelOne Inc (Class A) | David J. Bernhardt | Chief Financial Officer | 09 Feb 2024 | 90,000 | 437,153 | - | 3.0 | 271,800 | Class A Common Stock | |
| SentinelOne Inc (Class A) | David Bernhardt J. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 90,000 | 90,000 | - | - | Class B Common Stock | |
| SentinelOne Inc (Class A) | Bernhardt J. David | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 90,000 | 1,851,098 | - | - | Stock Option (right to buy) | |
| SentinelOne Inc (Class A) | J. David Bernhardt | Chief Financial Officer | 09 Feb 2024 | 90,000 | 0 | - | - | Class B Common Stock | ||
| EverQuote Inc (Class A) | David B. Blundin | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.00 per share. | 09 Feb 2024 | 89,177 | 802,589 (6%) | 0% | 15 | 1,337,655 | Class A Common Stock |
| Flowserve Corp | Scott R. Rowe | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 87,230 | 333,907 | - | - | Performance Rights | |
| Snowflake Inc (Class A) | Frank Slootman | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 232.89 per share. | 09 Feb 2024 | 86,820 | 262,611 | - | 232.9 | 20,219,857 | Class A Common Stock |
| Ryder System Inc | Sanchez Robert E. | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 85,132 | 147,515 (0%) | 0% | 0 | common stock | |
| American Healthcare REIT Inc | Mathieu B. Streiff | Director | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 09 Feb 2024 | 83,333 | 90,740 | - | 12 | 999,996 | Common Stock |
| American Healthcare REIT Inc | Danny Prosky | Director, CEO & President | Purchase of securities on an exchange or from another person at price $ 12.00 per share. | 09 Feb 2024 | 83,333 | 305,555 | - | 12 | 999,996 | Common Stock |
| Cbiz Inc | P. Jerome Grisko | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 81,362 | 163,294 (0%) | 0% | 0 | Common Stock | |
| American Eagle Outfitters Inc | L. Jay Schottenstein | Director, Exec Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 80,174 | 1,691,171 (1%) | 0% | 0 | Common Stock, without par value | |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Hult William | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 78,191 | 211,391 (0%) | 0% | 0 | Class A common stock | |
| Urban Edge Properties | Robert Milton C. | General Counsel and Secretary | 09 Feb 2024 | 77,848 | 77,848 | - | - | 2023 LTIPs | ||
| Snowflake Inc (Class A) | Frank Slootman | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 233.60 per share. | 09 Feb 2024 | 77,479 | 185,132 | - | 233.6 | 18,099,017 | Class A Common Stock |
| Voyager Therapeutics Inc | Todd Carter | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 77,000 | 77,000 | - | - | Stock Option (Right to Buy) | |
| Genie Energy Ltd (Class B) | S. Jonas Howard | Director, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.89 per share. | 09 Feb 2024 | 76,544 | 232,965 (0%) | 0% | 18.9 | 1,445,916 | Class B Common Stock, par value $.01 per share |
| EyePoint Pharma Inc | Nancy S. Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 74,681 | 126,889 (0%) | 0% | 0 | Common Stock | |
| EyePoint Pharma Inc | Nancy S. Lurker | Director, Executive Vice Chair | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 74,681 | 83,351 (0%) | 0% | 0 | Common Stock | |
| American Healthcare REIT Inc | Stefan K.L. Oh | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 74,074 | 74,074 | - | 0 | Common Stock | |
| Flowserve Corp | R. Rowe Scott | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 73,000 | 260,907 | - | - | Performance Rights | |
| Flowserve Corp | R. Rowe Scott | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 71,145 | 193,445 | - | - | Restricted Stock Units | |
| Crane NXT Co | Max Mitchell H. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 69,564 | 396,575 | - | 0 | COMMON STOCK | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 69,190 | 6,610 | - | - | Stock Option (right to buy) | |
| Rhythm Pharma Inc | Shulman Joseph | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 69,190 | 74,460 (0%) | 0% | 21.4 | 1,479,282 | Common Stock |
| Apollo Global (Class A) (New) | Belardi James R | Director, CEO of Athene Holding Ltd. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 68,363 | 0 (0%) | 0% | 0 | Common Stock | |
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 09 Feb 2024 | 68,210 | 7,445,668 (11%) | 0% | 83.3 | 5,684,621 | Common Stock | |
| VF Corp | Darrell Bracken | Director, President & Chief Exec Officer | Purchase of securities on an exchange or from another person at price $ 15.38 per share. | 09 Feb 2024 | 65,360 | 144,280 (0%) | 0% | 15.4 | 1,005,296 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.38 per share. | 09 Feb 2024 | 65,175 | 70,415 (0%) | 0% | 21.4 | 1,393,442 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 65,175 | 10,625 | - | - | Stock Option (right to buy) | |
| Illinois Tool Works | O'Herlihy Christopher A. | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 63,424 | 63,424 | - | - | Employee Stock Option | |
| Voyager Therapeutics Inc | Fahey Sandell Jacquelyn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 62,000 | 62,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | P. Peter Pfreundschuh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Yum Brands | David Gibbs W. | Director, Chief Executive Officer | 09 Feb 2024 | 58,693 | 198,100 (0%) | 0% | 130.3 | 7,645,937 | Common Stock | |
| Yum Brands | Gibbs David W. | Director, Chief Executive Officer | 09 Feb 2024 | 58,693 | 0 | - | - | Restricted Stock Units | ||
| Urban Edge Properties | Olson Jeffrey S. | Director, Chairman of the Board & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 55,736 | 55,736 | - | - | LTIP Units (2024 LTI Perf.) | |
| American Healthcare REIT Inc | Mark E. Foster | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 55,556 | 55,556 | - | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | Fung Cheng Chi | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 22.23 per share. | 09 Feb 2024 | 55,000 | 10,533,602 | - | 22.2 | 1,222,502 | Ordinary Shares |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Pluta Thomas | Director, President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 53,429 | 91,006 (0%) | 0% | 0 | Class A common stock | |
| Timken Co. | Kyle Richard | Director, President and CEO | 09 Feb 2024 | 51,817 | 408,410 (0%) | 0% | 0 | Common Stock | ||
| Dana Inc | K. Kamsickas James | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 50,616 | 603,150 (0%) | 0% | 0 | Common Stock, par value $0.01 | |
| Dana Inc | K. Kamsickas James | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 50,616 | 0 | - | - | Restricted Stock Units | |
| Sabre Corp | E. Sean Menke | Director, Executive Chair of the Board | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 09 Feb 2024 | 50,000 | 1,517,340 (0%) | 0% | 4.1 | 203,760 | Common Stock |
| Voyager Therapeutics Inc | Swartz Robin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 50,000 | 122,327 (0%) | 0% | 0 | Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 09 Feb 2024 | 50,000 | 416,465 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Josef Thomas Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 50,000 | 630,341 | - | - | Employee Stock Option (right to buy) | |
| Cloudflare Inc (Class A) | Josef Seifert Thomas | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 50,000 | 58,925 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Josef Thomas Seifert | Chief Financial Officer | 09 Feb 2024 | 50,000 | 8,925 | - | - | Class B Common Stock | ||
| Lyell Immunopharma Inc | Matthew Lang | Chief Business Officer | 09 Feb 2024 | 50,000 | 50,000 | - | 0 | Common Stock | ||
| Recursion Pharma Inc (Class A) | J. Mauro David | Chief Medical Officer | 09 Feb 2024 | 49,768 | 246,521 | - | 0 | Class A Common Stock | ||
| Booz Allen Hamilton Holding Corp (Class A) | D. Rozanski Horacio | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 145.69 per share. | 09 Feb 2024 | 49,000 | 557,411 (0%) | 0% | 145.7 | 7,138,810 | Class A Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.14 per share. | 09 Feb 2024 | 48,177 | 26,183 (0%) | 0% | 50.1 | 2,415,503 | Common Stock |
| Werner Enterprises Inc | Leathers J. Derek | Director, CEO & Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 48,080 | 486,810 (0%) | 0% | 0 | Common Stock | |
| Apollo Global (Class A) (New) | Belardi R James | Director, CEO of Athene Holding Ltd. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.93 per share. | 09 Feb 2024 | 46,802 | 272,483 (0%) | 0% | 109.9 | 5,144,944 | Common Stock |
| Kymera Therapeutics Inc | Jared Gollob | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 46,137 | 62,883 | - | - | Stock Option (Right to Buy) | |
| Kymera Therapeutics Inc | Gollob Jared | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 09 Feb 2024 | 46,137 | 120,846 | - | 2.1 | 95,965 | Common Stock |
| American Eagle Outfitters Inc | Jennifer Foyle M. | Global Brand President-aerie | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 45,814 | 278,273 (0%) | 0% | 0 | Common Stock, without par value | |
| Bancorp Inc | M. Damian Kozlowski | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 45,616 | 45,616 | - | - | Stock Option (right to buy) | |
| Harley-Davidson Inc | Jochen Zeitz | Director, President and CEO | 09 Feb 2024 | 45,308 | 90,619 | - | - | Restricted Stock Units | ||
| Harley-Davidson Inc | Zeitz Jochen | Director, President and CEO | 09 Feb 2024 | 45,308 | 635,128 (0%) | 0% | 0 | Common Stock | ||
| Viking Therapeutics Inc | Lian Brian | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 29.90 per share. | 09 Feb 2024 | 45,000 | 2,139,882 (2%) | 0% | 29.9 | 1,345,500 | Common Stock, par value $0.00001 per share |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 44,770 | 682,770 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 44,770 | 1,133,096 | - | - | Class B Common Stock | ||
| Roblox Corp (Class A) | P. Lee Anthony | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 09 Feb 2024 | 44,235 | 473,228 | - | 0 | Class A Common Stock | |
| Skywest Inc | Childs Russell | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Feb 2024 | 43,897 | 420,036 (0%) | 0% | 59.3 | 2,603,970 | Common Stock |
| Navient Corp | Fisher Joe | EVP, CFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 43,828 | 277,069 (0%) | 0% | 0 | Common Stock | |
| Vulcan Materials | J. Hill Thomas | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 42,826 | 79,547 (0%) | 0% | - | Common Stock | |
| Urban Edge Properties | Mooallem Jeffrey | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 41,925 | 41,925 | - | - | LTIP Units (2024 LTI Time) | |
| Conoco Phillips | Lance Ryan M. | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 112.66 per share. | 09 Feb 2024 | 41,778 | 92,919 (0%) | 0% | 112.7 | 4,706,743 | Common Stock |
| Neostellar Capital Corp | D. Mark Klein | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.54 per share. | 09 Feb 2024 | 41,273 | 1,076,666 (5%) | 0% | 3.5 | 146,106 | Common Stock |
| Compass Therapeutics Inc | Gordon L. Carl | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Ann Gray Mary | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Ferneau Phil | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Chiniara Ellen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Compass Therapeutics Inc | Richard S. Lindahl | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Lyell Immunopharma Inc | Lee Gary | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 52,700 | - | 0 | Common Stock | |
| Lyell Immunopharma Inc | Charles Newton | Chief Financial Officer | 09 Feb 2024 | 40,000 | 48,729 | - | 0 | Common Stock | ||
| Lyell Immunopharma Inc | Stephen Hill | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 48,928 | - | 0 | Common Stock | |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.09 per share. | 09 Feb 2024 | 40,000 | 0 | - | 44.1 | 1,763,448 | Class A Common Stock |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 825,001 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 40,000 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 40,000 | 885,001 | - | 0 | Class A Common Stock | |
| Ameriprise Financial | M. James Cracchiolo | Director, CHAIRMAN AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.84 per share. | 09 Feb 2024 | 39,834 | 228,170 (0%) | 0% | 179.8 | 7,163,747 | Common Stock |
| Ameriprise Financial | James M. Cracchiolo | Director, CHAIRMAN AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 39,834 | 0 | - | - | Employee Stock Option (right to buy) | |
| Kymera Therapeutics Inc | Gollob Jared | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 35.39 per share. | 09 Feb 2024 | 38,739 | 82,107 | - | 35.4 | 1,371,058 | Common Stock |
| Navient Corp | Joe Fisher | EVP, CFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 38,604 | 233,241 (0%) | 0% | 0 | Common Stock | |
| Navient Corp | Kane John | EVP & Group President | 09 Feb 2024 | 38,569 | 548,395 (0%) | 0% | 0 | Common Stock | ||
| Voyager Therapeutics Inc | Carter Todd | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 38,500 | 91,594 (0%) | 0% | 0 | Common Stock | |
| Flowserve Corp | Scott Rowe R. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 38,408 | 366,838 (0%) | 0% | 0 | Common Stock | |
| Cigna Group | David Cordani M. | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 139.22 per share. | 09 Feb 2024 | 38,065 | 367,386 (0%) | 0% | 139.2 | 5,299,409 | Common Stock, $.01 Par Value |
| Cigna Group | Cordani M. David | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 38,065 | 104,736 | - | - | Employee Stock Option (Right to Buy) | |
| Cigna Group | David M. Cordani | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 335.22 per share. | 09 Feb 2024 | 38,065 | 329,321 (0%) | 0% | 335.2 | 12,760,123 | Common Stock, $.01 Par Value |
| e.l.f. Beauty Inc | P. Amin Tarang | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 175.18 per share. | 09 Feb 2024 | 37,795 | 252,792 (0%) | 0% | 175.2 | 6,620,943 | Common Stock, $0.01 par value |
| e.l.f. Beauty Inc | P. Amin Tarang | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 37,795 | 201,242 | - | - | Stock Option (Right to Buy) | |
| e.l.f. Beauty Inc | P. Tarang Amin | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.00 per share. | 09 Feb 2024 | 37,795 | 290,587 (0%) | 0% | 17 | 642,515 | Common Stock, $0.01 par value |
| Kore Grp Holdings Inc | Tushar K. Sachdev | EVP & Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 37,066 | 74,129 | - | - | Restricted Stock Units | |
| Kore Grp Holdings Inc | Tushar Sachdev K. | EVP & Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 37,066 | 143,987 | - | 0 | Common Stock | |
| Kore Grp Holdings Inc | Bryan Lubel | Exec. VP., Connected Health | 09 Feb 2024 | 37,066 | 74,129 | - | - | Restricted Stock Units | ||
| Kore Grp Holdings Inc | Lubel Bryan | Exec. VP., Connected Health | 09 Feb 2024 | 37,066 | 117,742 | - | 0 | Common Stock | ||
| Cbiz Inc | P. Jerome Grisko | Director, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.07 per share. | 09 Feb 2024 | 36,491 | 126,803 (0%) | 0% | 66.1 | 2,410,960 | Common Stock |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.43 per share. | 09 Feb 2024 | 36,479 | 1 | - | 44.4 | 1,620,944 | Class A Common Stock |
| NAPCO Security Tech Inc | Spinelli M. Stephen | Senior Vice President of Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.02 per share. | 09 Feb 2024 | 35,928 | 35,928 (0%) | 0% | 10.0 | 359,999 | Common Stock |
| NAPCO Security Tech Inc | Spinelli Stephen M. | Senior Vice President of Sales | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 35,928 | 23,952 | - | - | Employee Stock Option (Right to Buy) | |
| Crane NXT Co | Mitchell H. Max | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 35,692 | 0 | - | - | 2021 Performance-Based Restricted Share Unit | |
| Cbiz Inc | Spurio Chris | President, Financial Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 35,644 | 218,108 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Wengel Kathryn E. | EVP, Chief TO and Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 35,638 | 0 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | E. Wengel Kathryn | EVP, Chief TO and Risk Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 90.44 per share. | 09 Feb 2024 | 35,638 | 102,533 (0%) | 0% | 90.4 | 3,223,101 | Common Stock |
| Cbiz Inc | Ware Grove | C.F.O. | 09 Feb 2024 | 35,184 | 304,456 (0%) | 0% | 0 | Common Stock | ||
| MACOM Tech Soln Holdings Inc | Susan Ocampo | Director, Ten Percent Owner | 09 Feb 2024 | 35,077 | 7,401,958 (11%) | 0% | 84.5 | 2,965,059 | Common Stock | |
| Enact Holdings Inc | Gupta Rohit | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 34,571 | 99,723 | - | - | Common Stock | |
| Enact Holdings Inc | Gupta Rohit | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 34,571 | 34,555 | - | - | Restricted Stock Units | |
| SentinelOne Inc (Class A) | Bernhardt J. David | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.03 per share. | 09 Feb 2024 | 34,021 | 403,132 | - | 30.0 | 1,021,657 | Class A Common Stock |
| Navient Corp | Kane John | EVP & Group President | 09 Feb 2024 | 33,971 | 509,826 (0%) | 0% | 0 | Common Stock | ||
| Tradeweb Markets Inc - Ordinary Shares Cls A | Furber Sara | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 33,881 | 93,442 (0%) | 0% | 0 | Class A common stock | |
| Urban Edge Properties | Mark J. Langer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 33,843 | 33,843 | - | - | LTIP Units (2024 LTI Time) | |
| Portland General Electric Co | M. Pope Maria | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 40.11 per share. | 09 Feb 2024 | 33,612 | 180,924 (0%) | 0% | 40.1 | 1,348,177 | Common Stock |
| Ryder System Inc | Robert Sanchez E. | Director, Chair and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 117.12 per share. | 09 Feb 2024 | 33,535 | 113,980 (0%) | 0% | 117.1 | 3,927,619 | common stock |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 44.08 per share. | 09 Feb 2024 | 32,704 | 7,296 | - | 44.1 | 1,441,720 | Class A Common Stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Enrico Bruni | Managing Director, Europe/Asia | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 32,305 | 85,021 (0%) | 0% | 0 | Class A common stock | |
| Neostellar Capital Corp | D. Klein Mark | Director, Chairman, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.39 per share. | 09 Feb 2024 | 32,285 | 1,117,939 (5%) | 0% | 3.4 | 109,446 | Common Stock |
| Cbiz Inc | P. Kouzelos Michael | President, Employee Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 32,242 | 346,787 (0%) | 0% | 0 | Common Stock | |
| Crane NXT Co | Max H. Mitchell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.19 per share. | 09 Feb 2024 | 32,236 | 364,339 | - | 60.2 | 1,940,285 | COMMON STOCK |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 31,493 | 295,853,533 | - | - | Class B Common Stock | ||
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 31,493 | 31,493 (0%) | 0% | 0 | Class A Common Stock | ||
| Hims & Hers Health Inc (Class A) | Okupe Oluyemi | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 09 Feb 2024 | 31,363 | 156,721 | - | 10.0 | 314,640 | Class A Common Stock |
| Conoco Phillips | L. Bullock William | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 31,176 | 0 | - | - | Stock Units | |
| Conoco Phillips | William L. Bullock | Executive Vice President & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 31,176 | 54,357 (0%) | 0% | - | Common Stock | |
| Voyager Therapeutics Inc | Sandell Fahey Jacquelyn | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 31,000 | 92,000 (0%) | 0% | 0 | Common Stock | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 30,391 | 60,778 | - | - | Restricted Stock Units | |
| Enact Holdings Inc | Rohit Gupta | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 30,391 | 130,114 | - | - | Common Stock | |
| Gartner | Eugene A. Hall | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 30,135 | 30,135 | - | - | Restricted Stock Units | |
| Lumen Tech Inc | James Fowler | Director | 09 Feb 2024 | 30,000 | 183,038 (0%) | 0% | 1.5 | 45,000 | Common Stock | |
| Voyager Therapeutics Inc | Pfreundschuh P. Peter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 30,000 | 179,433 (0%) | 0% | 0 | Common Stock | |
| Navient Corp | Mark L. Heleen | EVP, CLO & Secretary | 09 Feb 2024 | 29,803 | 430,044 (0%) | 0% | 0 | Common Stock | ||
| Ryder System Inc | Diez John J. | EVP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 29,610 | 136,497 (0%) | 0% | 0 | common stock | |
| Ryder System Inc | John Sensing Steven | President, Global SCS & DTS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 29,610 | 63,250 (0%) | 0% | 0 | common stock | |
| Sonic Automotive Inc (Class A) | B. Scott Smith | Director, Ten Percent Owner | 09 Feb 2024 | 29,431 | 385,274 (1%) | 0% | 0 | Class A Common Stock | ||
| Sonic Automotive Inc (Class A) | G. Marcus Smith | Director, Ten Percent Owner | 09 Feb 2024 | 29,431 | 87,938 (0%) | 0% | 0 | Class A Common Stock | ||
| Sonic Automotive Inc (Class A) | David Smith Bruton | Director, Chairman and CEO, Ten Percent Owner | 09 Feb 2024 | 29,431 | 620,373 (2%) | 0% | 0 | Class A Common Stock | ||
| Ameriprise Financial | Cracchiolo M. James | Director, CHAIRMAN AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 402.09 per share. | 09 Feb 2024 | 29,079 | 199,091 (0%) | 0% | 402.1 | 11,692,375 | Common Stock |
| Beacon Fin Corp | Zaitzeff A. Michael | Director | Sale of securities on an exchange or to another person at price $ 23.09 per share. | 09 Feb 2024 | 29,062 | 127,147 (0%) | 0% | 23.1 | 671,042 | Common Stock |
| Blackstone | Joseph Patrick Baratta | Director | Sale of securities on an exchange or to another person at price $ 128.04 per share. | 09 Feb 2024 | 28,452 | 982,621 (0%) | 0% | 128.0 | 3,642,994 | Common Stock |
| DraftKings Inc (Class A) | Paul Liberman | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,309 | 726,662 | - | - | Class A Common Stock | |
| DraftKings Inc (Class A) | Matthew Kalish | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,309 | 226,470 | - | - | Restricted Stock Units | |
| DraftKings Inc (Class A) | Liberman Paul | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,309 | 226,470 | - | - | Restricted Stock Units | |
| DraftKings Inc (Class A) | Kalish Matthew | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,309 | 3,397,181 | - | - | Class A Common Stock | |
| Illinois Tool Works | M. Michael Larsen | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 28,269 | 28,269 | - | - | Employee Stock Option | |
| KLX Energy Services Holdings Inc | Christopher J. Baker | Director, See Remarks | Sale or transfer of securities back to the company at price $ 8.95 per share. | 09 Feb 2024 | 28,192 | 250,458 (1%) | 0% | 8.9 | 252,318 | Common stock |
| KLX Energy Services Holdings Inc | Christopher J. Baker | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,192 | 56,382 | - | - | Restricted Stock Unit | |
| KLX Energy Services Holdings Inc | Christopher J. Baker | Director, See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 28,192 | 278,650 (1%) | 0% | - | Common stock | |
| Cheniere Energy Inc | A. Fusco Jack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 27,933 | 0 | - | - | Restricted Stock Units | |
| Cheniere Energy Inc | Jack Fusco A. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 27,933 | 773,681 (0%) | 0% | - | Common Stock | |
| Johnson & Johnson | Wengel Kathryn E. | EVP, Chief TO and Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.76 per share. | 09 Feb 2024 | 27,333 | 75,200 (0%) | 0% | 156.8 | 4,284,721 | Common Stock |
| Yum China Holdings Inc | Joey Wat | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 26,812 | 271,856 (0%) | 0% | 0 | Common Stock | |
| Yum China Holdings Inc | Wat Joey | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 26,812 | 54,437 | - | - | Restricted Stock Unit | |
| Yum Brands | Christopher Turner | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 26,484 | 26,484 | - | - | Stock Appreciation Right | |
| Hims & Hers Health Inc (Class A) | Okupe Oluyemi | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 26,385 | 1,004,922 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 09 Feb 2024 | 26,385 | 188,084 | - | 5.0 | 132,189 | Class A Common Stock |
| Navient Corp | Heleen L. Mark | EVP, CLO & Secretary | 09 Feb 2024 | 26,250 | 400,241 (0%) | 0% | 0 | Common Stock | ||
| Kore Grp Holdings Inc | Jack William Kennedy | EVP, Chief Legal Officer & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 25,946 | 51,891 | - | - | Restricted Stock Units | |
| Kore Grp Holdings Inc | Jack Kennedy William | EVP, Chief Legal Officer & Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 25,946 | 74,196 | - | 0 | Common Stock | |
| Kore Grp Holdings Inc | Louise P. Winstone | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 25,946 | 51,891 | - | - | Restricted Stock Units | |
| Kore Grp Holdings Inc | Winstone Louise P. | EVP, Chief HR Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 25,946 | 73,302 | - | 0 | Common Stock | |
| Kore Grp Holdings Inc | Paul Holtz | Exec. Vice Pres., CFO & Treas. | 09 Feb 2024 | 25,946 | 51,891 | - | - | Restricted Stock Units | ||
| Kore Grp Holdings Inc | Paul Holtz | Exec. Vice Pres., CFO & Treas. | 09 Feb 2024 | 25,946 | 69,016 | - | 0 | Common Stock | ||
| American Eagle Outfitters Inc | Jay Schottenstein L. | Director, Exec Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.48 per share. | 09 Feb 2024 | 25,838 | 1,665,333 (0%) | 0% | 22.5 | 580,838 | Common Stock, without par value |
| Bancorp Inc | Ryan Harris | EVP Head of Fintech Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 25,632 | 135,133 (0%) | 0% | - | Common Stock | |
| American Eagle Outfitters Inc | M. Jennifer Foyle | Global Brand President-aerie | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.48 per share. | 09 Feb 2024 | 25,336 | 252,937 (0%) | 0% | 22.5 | 569,553 | Common Stock, without par value |
| Host Hotels & Resorts - REIT | Risoleo F. James | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.58 per share. | 09 Feb 2024 | 25,308 | 1,877,399 (0%) | 0% | 19.6 | 495,531 | Common Stock |
| Yum Brands | Skeans L. Tracy | COO and CPO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 25,159 | 25,159 | - | - | Stock Appreciation Right | |
| Netflix | Ted Sarandos | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 79.58 per share. | 09 Feb 2024 | 25,130 | 26,408 (0%) | 0% | 79.6 | 1,999,737 | Common Stock |
| Netflix | Sarandos Ted | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 25,130 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Flagstar Fin Inc | Lee M. Smith | SEVP & President of Mortgage | Purchase of securities on an exchange or from another person at price $ 4.05 per share. | 09 Feb 2024 | 25,000 | 1,440,683 (0%) | 0% | 4.1 | 101,250 | Common Stock |
| Tradeweb Markets Inc - Ordinary Shares Cls A | Peterson Justin | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 24,890 | 69,105 (0%) | 0% | 0 | Class A common stock | |
| Flowserve Corp | Schwetz Amy B. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 24,746 | 87,214 | - | - | Restricted Stock Units | |
| Flowserve Corp | Schwetz Amy B. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 24,746 | 96,488 | - | - | Performance Rights | |
| Conoco Phillips | Dominic E. Macklon | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 24,379 | 0 | - | - | Stock Units | |
| Conoco Phillips | Dominic Macklon E. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 24,379 | 31,661 (0%) | 0% | - | Common Stock | |
| Dana Inc | Kamsickas K. James | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.62 per share. | 09 Feb 2024 | 24,326 | 582,419 (0%) | 0% | 13.6 | 331,320 | Common Stock, par value $0.01 |
| Host Hotels & Resorts - REIT | James F. Risoleo | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.58 per share. | 09 Feb 2024 | 23,827 | 1,882,163 (0%) | 0% | 19.6 | 466,533 | Common Stock |
| Werner Enterprises Inc | Derek Leathers J. | Director, CEO & Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.61 per share. | 09 Feb 2024 | 23,753 | 457,877 (0%) | 0% | 41.6 | 988,362 | Common Stock |
| Vulcan Materials | Thomas J. Hill | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 23,700 | 0 | - | - | Performance Share Units | |
| Resideo Tech Inc | Geldmacher L. Jay | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.90 per share. | 09 Feb 2024 | 23,458 | 463,671 (0%) | 0% | 19.9 | 466,814 | Common Stock |
| Rhythm Pharma Inc | Joseph Shulman | Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 50.88 per share. | 09 Feb 2024 | 23,397 | 2,786 (0%) | 0% | 50.9 | 1,190,503 | Common Stock |
| Cbiz Inc | P. Jerome Grisko | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 23,204 | 150,007 (0%) | 0% | 0 | Common Stock | |
| Enact Holdings Inc | Gupta Rohit | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.16 per share. | 09 Feb 2024 | 23,148 | 106,966 | - | 27.2 | 628,700 | Common Stock |
| Regeneron Pharma | P. Daniel Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 381.40 per share. | 09 Feb 2024 | 23,125 | 47,153 (0%) | 0% | 381.4 | 8,819,875 | Common Stock |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 23,125 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Yum Brands | David W. Gibbs | Director, Chief Executive Officer | 09 Feb 2024 | 23,119 | 174,981 (0%) | 0% | 130.3 | 3,011,712 | Common Stock | |
| Yum Brands | W. Gibbs David | Director, Chief Executive Officer | 09 Feb 2024 | 23,030 | 23,030 | - | - | Restricted Stock Units | ||
| Hims & Hers Health Inc (Class A) | Boughton Soleil | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share. | 09 Feb 2024 | 22,839 | 177,184 | - | 2.4 | 55,499 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Boughton Soleil | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 22,839 | 200,471 | - | - | Stock Option (right to buy) | |
| Hims & Hers Health Inc (Class A) | Soleil Boughton | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 10.03 per share. | 09 Feb 2024 | 22,839 | 154,345 | - | 10.0 | 229,125 | Class A Common Stock |
| Conoco Phillips | Rose Brunetti Kelly | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 22,792 | 0 | - | - | Stock Units | |
| Conoco Phillips | Brunetti Rose Kelly | SVP & General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 22,792 | 33,143 (0%) | 0% | - | Common Stock | |
| Netflix | Sarandos Ted | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 89.00 per share. | 09 Feb 2024 | 22,470 | 48,878 (0%) | 0% | 89.0 | 1,999,895 | Common Stock |
| Netflix | Sarandos Ted | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 22,470 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Ryder System Inc | Robert Sanchez E. | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 22,199 | 136,179 (0%) | 0% | 0 | common stock | |
| Yum Brands | Powell Aaron | CEO - Pizza Hut | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 22,070 | 22,070 | - | - | Stock Appreciation Right | |
| Yum Brands | Sabir Sami | Chief Executive Officer - KFC | 09 Feb 2024 | 22,070 | 22,070 | - | - | Employee Stock Option (Right to Buy) | ||
| Phillips 66 | G. Harbison Richard | EVP, Refining | Sale of securities on an exchange or to another person at price $ 146.27 per share. | 09 Feb 2024 | 21,934 | 24,941 (0%) | 0% | 146.3 | 3,208,286 | Common Stock |
| Cheniere Energy Inc | Fusco Jack A. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 21,685 | 0 | - | - | Restricted Stock Units | |
| Cheniere Energy Inc | Fusco Jack A. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 21,685 | 767,433 (0%) | 0% | - | Common Stock | |
| Timken Co. | Richard Kyle | Director, President and CEO | 09 Feb 2024 | 21,611 | 386,799 (0%) | 0% | 81.1 | 1,751,788 | Common Stock | |
| Netflix | Sarandos Ted | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 21,357 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Netflix | Sarandos Ted | Director, Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 93.64 per share. | 09 Feb 2024 | 21,357 | 70,235 (0%) | 0% | 93.6 | 1,999,778 | Common Stock |
| Navient Corp | M. Stephen Hauber | EVP, Chief Risk&Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 21,037 | 269,656 (0%) | 0% | 0 | Common Stock | |
| Colgate-Palmolive | W. Kooyman John | Chief of Staff | Exercise or conversion of derivative security received from the company (such as an option) at price $ 68.16 per share. | 09 Feb 2024 | 21,023 | 26,305 (0%) | 0% | 68.2 | 1,432,928 | Common Stock |
| Colgate-Palmolive | John W. Kooyman | Chief of Staff | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 21,023 | 0 | - | - | Stock Option (Right to Buy) | |
| Colgate-Palmolive | W. John Kooyman | Chief of Staff | Sale of securities on an exchange or to another person at price $ 83.60 per share. | 09 Feb 2024 | 21,023 | 5,282 (0%) | 0% | 83.6 | 1,757,458 | Common Stock |
| NMI Holdings Inc (Class A) | Mallela Ravi | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 09 Feb 2024 | 20,956 | 92,908 (0%) | 0% | 0 | Class A Common Shares, $0.01 par value per share | |
| Flowserve Corp | Schwetz B. Amy | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,750 | 75,738 | - | - | Performance Rights | |
| Yum Brands | Catlett Scott | Chief Legal &Franchise Officer | 09 Feb 2024 | 20,746 | 20,746 | - | - | Stock Appreciation Right | ||
| Beacon Fin Corp | Zaitzeff A. Michael | Director | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 09 Feb 2024 | 20,718 | 156,209 (0%) | 0% | 22.7 | 471,024 | Common Stock |
| Bancorp Inc | DeRowe Olek | EVP Head Commercial RE | 09 Feb 2024 | 20,505 | 91,308 (0%) | 0% | - | Common Stock | ||
| EyePoint Pharma Inc | Lurker Nancy S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 20,000 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | S. Nancy Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 155,441 (0%) | 0% | 0 | Common Stock | |
| Roblox Corp (Class A) | David Baszucki | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 865,001 | - | 0 | Class A Common Stock | |
| Roblox Corp (Class A) | Baszucki David | Director, President & CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 925,001 | - | 0 | Class A Common Stock | |
| Walker & Dunlop Inc | Howard W. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 20,000 | 20,166 | - | - | Common Stock | |
| Walker & Dunlop Inc | Smith Howard W. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.72 per share. | 09 Feb 2024 | 20,000 | 211,508 (0%) | 0% | 16.7 | 334,400 | Common Stock |
| Agenus Inc | Garo Armen H. | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.75 per share. | 09 Feb 2024 | 19,778 | 1,231,514 (0%) | 0% | 0.8 | 14,834 | Common Stock |
| Regency Centers - REIT | Lisa Palmer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 19,290 | 19,290 | - | - | Restricted Stock | |
| Bentley Systems Inc (Class B) | Andre Werner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 19,226 | 0 | - | - | Stock Options (Right to Buy) | |
| Bentley Systems Inc (Class B) | Andre Werner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.74 per share. | 09 Feb 2024 | 19,226 | 270,331 | - | 5.7 | 110,357 | Class B Common Stock |
| Vulcan Materials | Thomas Hill J. | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.44 per share. | 09 Feb 2024 | 19,007 | 60,540 (0%) | 0% | 238.4 | 4,532,029 | Common Stock |
| SkyWater Tech Inc | Thomas Sonderman | Director, CEO | Sale of securities on an exchange or to another person at price $ 10.01 per share. | 09 Feb 2024 | 18,989 | 498,413 | - | 10.0 | 190,023 | Common Stock |
| Netflix | Ted Sarandos | Director, Co-CEO | Sale of securities on an exchange or to another person at price $ 561.77 per share. | 09 Feb 2024 | 18,958 | 17,398 (0%) | 0% | 561.8 | 10,650,102 | Common Stock |
| Zurn Elkay Water Soln Corp | Michael D. Troutman | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 18,944 | 50,952 (0%) | 0% | - | Common Stock | |
| Universal Electronics Inc | Arling Paul D. | Director, CEO | 09 Feb 2024 | 18,843 | 88,836 | - | - | Restricted Stock Units | ||
| Universal Electronics Inc | D. Arling Paul | Director, CEO | 09 Feb 2024 | 18,843 | 277,787 (1%) | 0% | - | Common Stock | ||
| Bancorp Inc | A. Nager Jeffrey | EVP Head of Commercial Lending | 09 Feb 2024 | 18,796 | 121,057 (0%) | 0% | - | Common Stock | ||
| Bancorp Inc | John Leto | EVP Head of Institutional Bank | 09 Feb 2024 | 18,796 | 228,223 (0%) | 0% | - | Common Stock | ||
| Beacon Fin Corp | Zaitzeff Michael A. | Director | Sale of securities on an exchange or to another person at price $ 21.93 per share. | 09 Feb 2024 | 18,700 | 108,447 (0%) | 0% | 21.9 | 410,179 | Common Stock |
| Navient Corp | Stephen M. Hauber | EVP, Chief Risk&Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 18,529 | 248,619 (0%) | 0% | 0 | Common Stock | |
| Ryder System Inc | D. Robert Fatovic | EVP, CLO & Corp. Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 18,506 | 70,820 (0%) | 0% | 0 | common stock | |
| Resideo Tech Inc | Jay Geldmacher L. | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.44 per share. | 09 Feb 2024 | 18,451 | 487,129 (0%) | 0% | 17.4 | 321,785 | Common Stock |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 18,125 | 1,584,530 (1%) | 0% | 0 | Common Stock | |
| Enphase Energy | Badri Kothandaraman | Director, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 09 Feb 2024 | 18,125 | 50,766 (0%) | 0% | 0 | Common Stock | |
| Harley-Davidson Inc | Zeitz Jochen | Director, President and CEO | 09 Feb 2024 | 18,101 | 617,027 (0%) | 0% | 36.9 | 667,022 | Common Stock | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 17,925 | 17,925 (0%) | 0% | 0 | Class A Common Stock | ||
| Meta | Zuckerberg Mark | Director, COB and CEO, Ten Percent Owner | 09 Feb 2024 | 17,925 | 3,841,616 | - | - | Class B Common Stock | ||
| Yum Brands | Sean Tresvant | Taco Bell, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 17,656 | 17,656 | - | - | Stock Appreciation Right | |
| EyePoint Pharma Inc | Nancy S. Lurker | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,534 | 0 | - | - | Restricted Stock Units | |
| EyePoint Pharma Inc | Nancy Lurker S. | Director, Executive Vice Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,534 | 172,975 (0%) | 0% | 0 | Common Stock | |
| Snowflake Inc (Class A) | Slootman Frank | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 229.63 per share. | 09 Feb 2024 | 17,334 | 370,702 | - | 229.6 | 3,980,320 | Class A Common Stock |
| Bancorp Inc | Connolly Mark L. | EVP and Head of Credit Markets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 17,088 | 227,228 (0%) | 0% | - | Common Stock | |
| Bancorp Inc | J. Garry Gregor | EVP and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 17,088 | 120,396 (0%) | 0% | - | Common Stock | |
| Black Hills Corp | Linden R. Evans | President and CEO | Grant, award, or other acquisition of securities at price $ 51.62 per share. | 09 Feb 2024 | 17,031 | 157,267 (0%) | 0% | 51.6 | 879,140 | Common Stock |
| Cheniere Energy Inc | Jack A. Fusco | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,004 | 762,752 (0%) | 0% | - | Common Stock | |
| Cheniere Energy Inc | Fusco A. Jack | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 17,004 | 34,008 | - | - | Restricted Stock Units | |
| Cheniere Energy Inc | A. Jack Fusco | Director, President and CEO | Sale or transfer of securities back to the company at price $ 167.13 per share. | 09 Feb 2024 | 16,941 | 756,740 (0%) | 0% | 167.1 | 2,831,349 | Common Stock |
| Urban Edge Properties | Jeffrey Mooallem | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 16,908 | 16,908 | - | - | LTIP Units (2024 LTI Perf.) | |
| Amcor | J Guerra Karen | Director | Sale of securities on an exchange or to another person at price $ 9.02 per share. | 09 Feb 2024 | 16,835 | 83,589 (0%) | 0% | 9.0 | 151,852 | Ordinary Shares |
| Conoco Phillips | Nicholas G. Olds | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 16,730 | 0 | - | - | Stock Units | |
| Conoco Phillips | G. Olds Nicholas | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 16,730 | 19,808 (0%) | 0% | - | Common Stock | |
| Regeneron Pharma | Daniel P. Van Plew | EVP & General Mgr, Industrial | Payment of exercise price or tax liability using portion of securities received from the company at price $ 951.68 per share. | 09 Feb 2024 | 16,341 | 30,812 (0%) | 0% | 951.7 | 15,551,403 | Common Stock |
| Ametek | J. Oscher Ronald | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 16,210 | 0 | - | - | Stock Option | |
| Ametek | Oscher J. Ronald | CHIEF ADMINISTRATIVE OFFICER | Sale of securities on an exchange or to another person at price $ 168.21 per share. | 09 Feb 2024 | 16,210 | 33,674 (0%) | 0% | 168.2 | 2,726,723 | Common Stock |
| Ametek | J. Ronald Oscher | CHIEF ADMINISTRATIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 73.45 per share. | 09 Feb 2024 | 16,210 | 49,884 (0%) | 0% | 73.5 | 1,190,625 | Common Stock |
| NAPCO Security Tech Inc | Richard L. Soloway | Director, President, CEO and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 16,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| NAPCO Security Tech Inc | Richard Soloway L. | Director, President, CEO and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.08 per share. | 09 Feb 2024 | 16,000 | 3,718,010 (20%) | 0% | 8.1 | 129,280 | Common Stock |
| NAPCO Security Tech Inc | Soloway L. Richard | Director, President, CEO and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 16,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| NAPCO Security Tech Inc | Soloway L. Richard | Director, President, CEO and Secretary, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.80 per share. | 09 Feb 2024 | 16,000 | 3,734,010 (20%) | 0% | 16.8 | 268,720 | Common Stock |
| Cbiz Inc | Chris Spurio | President, Financial Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.07 per share. | 09 Feb 2024 | 15,988 | 202,120 (0%) | 0% | 66.1 | 1,056,327 | Common Stock |
| Yum Brands | David Russell | Vice President, Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,890 | 15,890 | - | - | Stock Appreciation Right | |
| Cbiz Inc | Grove Ware | C.F.O. | 09 Feb 2024 | 15,781 | 288,675 (0%) | 0% | 66.1 | 1,042,651 | Common Stock | |
| Equifax | Mark Begor W. | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,662 | 15,662 | - | - | Stock Option/Right to Buy | |
| Timken Co. | Coughlin Christopher | EVP & Pres. Industrial Motion | 09 Feb 2024 | 15,607 | 110,469 (0%) | 0% | 0 | Common Stock | ||
| Kore Grp Holdings Inc | Lubel Bryan | Exec. VP., Connected Health | 09 Feb 2024 | 15,487 | 102,255 | - | 1.0 | 14,713 | Common Stock | |
| DraftKings Inc (Class A) | Park K. Jason | Chief Financial Officer | 09 Feb 2024 | 15,428 | 123,426 | - | - | Restricted Stock Units | ||
| DraftKings Inc (Class A) | Park K. Jason | Chief Financial Officer | 09 Feb 2024 | 15,428 | 274,840 | - | - | Class A Common Stock | ||
| Skywest Inc | J. Wade Steel | CHIEF COMMERCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Feb 2024 | 15,338 | 133,073 (0%) | 0% | 59.3 | 909,850 | Common Stock |
| Skywest Inc | Simmons Robert J. | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.32 per share. | 09 Feb 2024 | 15,337 | 155,008 (0%) | 0% | 59.3 | 909,791 | Common Stock |
| Snowflake Inc (Class A) | Frank Slootman | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 231.81 per share. | 09 Feb 2024 | 15,336 | 349,431 | - | 231.8 | 3,555,023 | Class A Common Stock |
| Fiserv | Bisignano Frank J. | Director, Chairman, President and CEO | 09 Feb 2024 | 15,332 | 2,932,780 (0%) | 0% | 0 | Common Stock | ||
| Kore Grp Holdings Inc | Paul Holtz | Exec. Vice Pres., CFO & Treas. | 09 Feb 2024 | 15,228 | 53,788 | - | 1.0 | 14,467 | Common Stock | |
| Sonoco Products Co. | Howard Coker R. | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 15,126 | 273,161 (0%) | 0% | 0 | Common Stock | |
| Sonoco Products Co. | Howard Coker R. | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 15,126 | 15,585 | - | - | Restricted Stock Units | |
| Flowserve Corp | Scott R. Rowe | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.50 per share. | 09 Feb 2024 | 15,066 | 351,772 (0%) | 0% | 41.5 | 625,239 | Common Stock |
| Flagstar Fin Inc | L. David Treadwell | Director | Purchase of securities on an exchange or from another person at price $ 4.17 per share. | 09 Feb 2024 | 15,000 | 173,900 (0%) | 0% | 4.2 | 62,550 | Common Stock |
| RenovoRx Inc | B. Ronald Kocak | VP, Controller and PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 15,000 | 15,000 | - | - | Options | |
| Vestis Corp | Kim Scott | Director, President and CEO | 09 Feb 2024 | 15,000 | 183,130 | - | 19.1 | 287,175 | Common Stock, par value $0.01 per share | |
| Meta | Mark Zuckerberg | Director, COB and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 470.04 per share. | 09 Feb 2024 | 14,993 | 646,244 (0%) | 0% | 470.0 | 7,047,298 | Class A Common Stock |
| Navient Corp | Linda A. Mills | Director | 09 Feb 2024 | 14,823 | 152,915 (0%) | 0% | 16.2 | 239,984 | Common Stock | |
| Walker & Dunlop Inc | W. Smith Howard | Director | Sale of securities on an exchange or to another person at price $ 93.62 per share. | 09 Feb 2024 | 14,776 | 196,732 (0%) | 0% | 93.6 | 1,383,319 | Common Stock |
| Neuronetics Inc | Stephen Furlong | EVP, CFO and Treasurer | 09 Feb 2024 | 14,710 | 509,033 (2%) | 0% | 3.5 | 51,632 | Common Stock | |
| Hawaiian Electric Ind Inc | Teranishi Ann | Pres & CEO, Amer Savings Bank | 09 Feb 2024 | 14,709 | 25,432 (0%) | 0% | 0 | Common Stock | ||
| American Eagle Outfitters Inc | A. Michael Mathias | EVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 14,704 | 84,740 (0%) | 0% | 0 | Common Stock, without par value | |
| Merck & Company | Dean Li Y. | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 14,702 | 0 | - | - | Stock Option (Right to Buy) | |
| Merck & Company | Li Dean Y. | Executive VP & President, MRL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 62.07 per share. | 09 Feb 2024 | 14,702 | 60,944 (0%) | 0% | 62.1 | 912,553 | Common Stock |
| Merck & Company | Y. Dean Li | Executive VP & President, MRL | Sale of securities on an exchange or to another person at price $ 125.50 per share. | 09 Feb 2024 | 14,702 | 46,242 (0%) | 0% | 125.5 | 1,845,083 | Common Stock |
| Timken Co. | Philip D. Fracassa | EVP & CFO | 09 Feb 2024 | 14,622 | 120,587 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.